// App-Quantinova.ai

: Donor Hepatitis C Seropositivity Confers Poorer Post-transplant Outcomes In Recipients Of Marginal Livers In The Post-hepatitis C Treatment Era

Researchers

Presenter

  • M. B. Shah

Principal Investigators

  • M. Gupta

  • X. Mei

  • R. Gedaly

Medical Centers

  • University of Kentucky, Lexington, KY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Infectious Diseases (ID)

Disease

  • Hepatitis C

  • Venous thrombosis

Biomarkers

  • Optineurin

  • Estrogen receptor alpha

  • Body mass index

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved